Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: J.F. who wrote (23027)	2/21/2007 2:06:03 PM
From: Galirayo	Read Replies (1) \| Respond to of 23958

I don't mean to mention ... "The Hated One" but there's a of a Lot of Volume going thru since Earnings ... the last week or so. stockcharts.com

To: J.F. who wrote (23027)	2/22/2007 8:33:42 AM
From: J.F.	Read Replies (2) \| Respond to of 23958

MEMY - ouch! Memory Pharmaceuticals Corp.'s (MEMY) fourth-quarter loss widened to $14.7 million, or 23 cents a share, from $3.65 million, or 10 cents, a year earlier. The Montvale, N.J., drug developer said Thursday results for the latest period included a loss of $6.05 million for warrants issued in the company's September 2005 private placement and a share-based compensation charge of $544,000. The biopharmaceutical company posted a loss of $8.14 million, or 13 cents a share, before items for the latest period. Total operating costs rose to $12.3 million from $10.2 million. Memory Pharmaceuticals' fourth-quarter revenue fell to $2.64 million from $3.71 million. jf...